The Largest Transactions in the Cannabis Space



CMC, Intellectual Property Validation, Regulatory, QA/QC, Licensing, Biosynthesis, Cannabis & Natural Health Formulation & Finished Products, Facility Audits, Facility Design & Floor Planning, Formulation and Drug Delivery




To provide expertise in product and business development in the Cannabis space.


Our pharmaceutical network and knowledge gives us a significant advantage in the Cannabis space of drug development and due diligence

Our Cannabis drug development experts have supported the largest marquee transactions in the cannabis space. Our experts advise companies in areas of biosynthesis and synthetic chemistry,  plant genetics and cultivation, formulation and drug delivery, intellectual property development, facility audits and licensing. Our quality team conducts one audit per week (over 50 per year).


"We've worked with Novateur on a number of scientific due diligence mandates and have been consistently impressed with their diligence capabilities, professional behavior and work ethics, level of service, can-do attitude, and quality of insights. Novateur has exceeded my expectations as an engagement partner." 

Rami El-Cheikh, MBA, CMA, PMP
Partner, PwC

Novateur Newsletter

Subscribe to our newsletter for access to latest updates.

Resource Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant Events

Check out conferences and events we are attending!